Thyroid dysfunction in patients with type 1 diabetes: a longitudinal study.

OBJECTIVE Cross-sectional studies have reported that the risk of thyroid dysfunction in patients with type 1 diabetes is two- to threefold higher than in the general population. However, longitudinal studies to determine the natural history of thyroid dysfunction in patients with type 1 diabetes are lacking. RESEARCH DESIGN AND METHODS We analyzed the incidence of thyroid dysfunction over time in a cohort of 58 patients (26 men and 32 women) enrolled in the Diabetes Control and Complications Trial at the University of Tennessee Health Science Center in 1983 and prospectively followed for 18 years. Patients underwent measurement of thyroid function tests (thyroid-stimulating hormone [TSH], thyroxine, and triiodothyronine) every year and thyroid peroxidase (TPO) antibodies at 4-year intervals. RESULTS A total of 18 patients had hypothyroidism, and 1 patient experienced transient hyperthyroidism. Two subjects developed hypothyroidism 7 and 18 years before the development of diabetes and were excluded from the analysis. The mean age of diagnosis was 19 +/- 2 years for type 1 diabetes and 29 +/- 3 years for hypothyroidism. Hypothyroidism was more common in female (41%) than in male (19%) subjects and in patients with positive TPO antibodies. Patients who were TPO positive were 17.91 times as likely to develop hypothyroidism as patients who were TPO negative (95% CI 3.89-82.54). There were no differences in BMI, lipid profile, and HbA(1c) between patients with and without thyroid dysfunction. CONCLUSIONS This longitudinal study confirms the association between autoimmune thyroid dysfunction and type 1 diabetes. Our results indicate that all subjects with type 1 diabetes should undergo annual screening by serum TSH measurement to detect asymptomatic thyroid dysfunction, particularly those with positive TPO antibodies.

[1]  W Harry Hannon,et al.  Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). , 2002, The Journal of clinical endocrinology and metabolism.

[2]  G. Canaris,et al.  The Colorado thyroid disease prevalence study. , 2000, Archives of internal medicine.

[3]  A. Hofman,et al.  Subclinical Hypothyroidism Is an Independent Risk Factor for Atherosclerosis and Myocardial Infarction in Elderly Women: The Rotterdam Study , 2000, Annals of Internal Medicine.

[4]  F. Greenspan,et al.  The Effect of Thyroid Hormone on Skeletal Integrity , 1999, Annals of Internal Medicine.

[5]  D. Cooper.  Subclinical Thyroid Disease: A Clinician's Perspective , 1998, Annals of Internal Medicine.

[6]  M. Helfand,et al.  Screening for Thyroid Disease: An Update , 1998, Annals of Internal Medicine.

[7]  L. Crapo,et al.  The epidemiology of thyroid disease and implications for screening. , 1997, Endocrinology and metabolism clinics of North America.

[8]  B. Frier,et al.  Frequency of Thyroid Dysfunction in Diabetic Patients: Value of Annual Screening , 1995, Diabetic medicine : a journal of the British Diabetic Association.

[9]  J. French,et al.  The incidence of thyroid disorders in the community: a twenty‐year follow‐up of the Whickham Survey , 1995, Clinical endocrinology.

[10]  R. Lorini,et al.  Frequency of Hashimoto's thyroiditis in children with type 1 diabetes mellitus , 1995, Acta Diabetologica.

[11]  E. Krenning,et al.  The importance of thyroid microsomal antibodies in the development of elevated serum TSH in middle‐aged women: associations with serum lipids , 1993, Clinical endocrinology.

[12]  J. Franklyn,et al.  Prevalence and follow‐up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom , 1991, Clinical endocrinology.

[13]  R. Eggertsen,et al.  Screening for thyroid disease in a primary care unit with a thyroid stimulating hormone assay with a low detection limit. , 1988, BMJ.

[14]  The Diabetes Control and Complications Trial (DCCT): Design and Methodologic Considerations for the Feasibility Phase , 1986, Diabetes.

[15]  N. Abourizk,et al.  Diabetes Mellitus and Thyroid Disease , 1983, Diabetes Care.

[16]  D. Lezotte,et al.  Thyroid autoimmunity in insulin-dependent diabetes mellitus: the case for routine screening. , 1981, The Journal of pediatrics.

[17]  B. Clarke,et al.  Screening for thyroid dysfunction in diabetics. , 1979, British medical journal.

[18]  M. Fell.  Antenatal prediction of fetal sex. , 1979, British medical journal.

[19]  F. Azizi,et al.  The aging thyroid. Increased prevalence of elevated serum thyrotropin levels in the elderly. , 1979, JAMA.

[20]  J. Feely,et al.  Screening for thyroid dysfunction in diabetics. , 1979, British medical journal.

[21]  D. Appleton,et al.  THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY , 1977, Clinical endocrinology.

[22]  J. Nerup,et al.  Thyroid, gastric and adrenal auto-immunity in diabetes mellitus. , 1973, Acta endocrinologica.

[23]  Sidney H. Ingbar,et al.  The Thyroid Gland. , 1965 .

[24]  W. Tamborlane,et al.  Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. , 1999, Diabetes care.

[25]  M. Helfand,et al.  Clinical guideline, part 2. Screening for thyroid disease: an update. American College of Physicians. , 1998, Annals of internal medicine.